French drug maker Sanofi SA told employees today that it will be shuttering a research lab in Bridgewater, N.J., next year and moving an unspecified number of jobs to the Boston area, where it has established its US research and development hub.
The step is part of a series of moves that will consolidate Sanofi’s global research operations while reducing its sales force across the United States, including a small number of jobs in Massachusetts.
Overall, the company, which bought Cambridge’s Genzyme Corp. earlier this year and is using it as a platform for its rare-disease business, has said it expects its 5,000-person Massachusetts workforce will remain stable.
“I can definitively say some research and development jobs will move into the Boston area, but I can’t put a number on it,” said Sanofi spokesman Jack Cox.
Sanofi has about 3,000 employees in New Jersey, including its US corporate staff and a research lab that focuses on preclinical and clinical development for a number of global therapeutic programs. Sanofi does not break out how many researchers and scientists are employed in the lab.
No comments:
Post a Comment